Steris (STE) FCF Payout Ratio Growth (3y) (2021 - 2026)
Steris (STE) FCF Payout Ratio Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -24.36% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -15.73% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 0.06% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 47.27% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -478.95% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 0.49% |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | -16.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.49% |
| Mar 31, 2026 | -7.92% |
| Dec 31, 2025 | 9.30% |
| Sep 30, 2025 | -48.34% |
| Jun 30, 2025 | -22.60% |
| Mar 31, 2025 | 10.97% |
| Dec 31, 2024 | -4.34% |
| Sep 30, 2024 | -6.00% |
| Jun 30, 2024 | -31.91% |
| Mar 31, 2024 | 50.99% |
| Dec 31, 2023 | -64.93% |
| Sep 30, 2023 | 41.49% |
| Jun 30, 2023 | -22.66% |
| Dec 31, 2022 | -57.34% |
| Sep 30, 2022 | 93.70% |
| Jun 30, 2022 | -8.46% |
| Mar 31, 2022 | -14.00% |
| Dec 31, 2021 | -8.63% |
| Sep 30, 2021 | 13.00% |
| Jun 30, 2021 | 32.28% |